Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 270

1.

Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues.

Cella M, Gamini R, Sécca C, Collins PL, Zhao S, Peng V, Robinette ML, Schettini J, Zaitsev K, Gordon W, Bando JK, Yomogida K, Cortez V, Fronick C, Fulton R, Lin LL, Gilfillan S, Flavell RA, Shan L, Artyomov MN, Bowman M, Oltz EM, Jelinsky SA, Colonna M.

Nat Immunol. 2019 Jun 17. doi: 10.1038/s41590-019-0425-y. [Epub ahead of print]

PMID:
31209406
2.

Concentration-QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase-4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT Prolongation.

Jolling K, Äbelö A, Luyckx N, Nandeuil MA, Govoni M, Cella M, Lindauer A.

CPT Pharmacometrics Syst Pharmacol. 2019 May 11. doi: 10.1002/psp4.12405. [Epub ahead of print]

3.

Blending active and passive digital technology methods to improve symptom monitoring in early psychosis.

Cella M, He Z, Killikelly C, Okruszek Ł, Lewis S, Wykes T.

Early Interv Psychiatry. 2019 Feb 28. doi: 10.1111/eip.12796. [Epub ahead of print]

PMID:
30821079
4.

Nuclear receptor ligands induce TREM-1 expression on dendritic cells: analysis of their role in tumors.

Fontana R, Raccosta L, Rovati L, Steffensen KR, Paniccia A, Jakobsson T, Melloni G, Bandiera A, Mangili G, Bergamini A, Maggioni D, Doglioni C, Crocchiolo R, Cella M, Mattioli M, Battaglia C, Colonna M, Russo V.

Oncoimmunology. 2018 Dec 13;8(3):1554967. doi: 10.1080/2162402X.2018.1554967. eCollection 2019.

PMID:
30723587
5.

A Cross-National Investigation of Hallucination-Like Experiences in 10 Countries: The E-CLECTIC Study.

Siddi S, Ochoa S, Laroi F, Cella M, Raballo A, Saldivia S, Quijada Y, Laloyaux J, Rocha NB, Lincoln TM, Schlier B, Ntouros E, Bozikas VP, Gaweda L, Machado S, Nardi AE, Rodante D, Deshpande SN, Haro JM, Preti A.

Schizophr Bull. 2019 Feb 1;45(45 Suppl 1):S43-S55. doi: 10.1093/schbul/sby156.

6.

Potential Applications of Digital Technology in Assessment, Treatment, and Self-help for Hallucinations.

Thomas N, Bless JJ, Alderson-Day B, Bell IH, Cella M, Craig T, Delespaul P, Hugdahl K, Laloyaux J, Larøi F, Lincoln TM, Schlier B, Urwyler P, van den Berg D, Jardri R.

Schizophr Bull. 2019 Feb 1;45(45 Suppl 1):S32-S42. doi: 10.1093/schbul/sby103. Review.

7.

Gene Regulatory Programs Conferring Phenotypic Identities to Human NK Cells.

Collins PL, Cella M, Porter SI, Li S, Gurewitz GL, Hong HS, Johnson RP, Oltz EM, Colonna M.

Cell. 2019 Jan 10;176(1-2):348-360.e12. doi: 10.1016/j.cell.2018.11.045. Epub 2018 Dec 27.

PMID:
30595449
8.

Factor mixture analysis of paranoia in young people.

Preti A, Massidda D, Cella M, Raballo A, Scanu R, Tronci D, Gabbrielli M, Muratore T, Carta MG, Petretto DR.

Soc Psychiatry Psychiatr Epidemiol. 2019 Mar;54(3):355-367. doi: 10.1007/s00127-018-1642-7. Epub 2018 Dec 12.

PMID:
30542959
9.

Seq-ing out the Killers of Mice and Men.

Peng V, Cella M.

Immunity. 2018 Nov 20;49(5):793-795. doi: 10.1016/j.immuni.2018.11.007.

PMID:
30462994
10.

Measuring attitudes towards mental health using social media: investigating stigma and trivialisation.

Robinson P, Turk D, Jilka S, Cella M.

Soc Psychiatry Psychiatr Epidemiol. 2019 Jan;54(1):51-58. doi: 10.1007/s00127-018-1571-5. Epub 2018 Aug 1.

11.

Exploring the relationship between the anticipation and experience of pleasure in people with schizophrenia: An experience sampling study.

Edwards CJ, Cella M, Emsley R, Tarrier N, Wykes THM.

Schizophr Res. 2018 Dec;202:72-79. doi: 10.1016/j.schres.2018.06.040. Epub 2018 Jul 7.

12.

Why is change a challenge in acute mental health wards? A cross-sectional investigation of the relationships between burnout, occupational status and nurses' perceptions of barriers to change.

Laker C, Cella M, Callard F, Wykes T.

Int J Ment Health Nurs. 2019 Feb;28(1):190-198. doi: 10.1111/inm.12517. Epub 2018 Jul 11.

PMID:
29993168
13.

Cognitive Remediation Therapy for Psychotic Major Depressive Disorder.

Allan S, Cella M, Wykes T, Perez J.

Prim Care Companion CNS Disord. 2018 Jun 14;20(3). pii: 17l02180. doi: 10.4088/PCC.17l02180. No abstract available.

14.

The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells.

Bando JK, Gilfillan S, Song C, McDonald KG, Huang SC, Newberry RD, Kobayashi Y, Allan DSJ, Carlyle JR, Cella M, Colonna M.

Immunity. 2018 Jun 19;48(6):1208-1219.e4. doi: 10.1016/j.immuni.2018.04.012. Epub 2018 May 29.

15.

Using ERPs to explore the impact of affective distraction on working memory stages in schizophrenia.

Okruszek Ł, Jarkiewicz M, Gola M, Cella M, Łojek E.

Cogn Affect Behav Neurosci. 2018 Jun;18(3):437-446. doi: 10.3758/s13415-018-0578-4.

16.

The CIRCuiTS study (Implementation of cognitive remediation in early intervention services): protocol for a randomised controlled trial.

Wykes T, Joyce E, Velikonja T, Watson A, Aarons G, Birchwood M, Cella M, Dopson S, Fowler D, Greenwood K, Johnson S, McCrone P, Perez J, Pickles A, Reeder C, Rose D, Singh S, Stringer D, Taylor M, Taylor R, Upthegrove R.

Trials. 2018 Mar 15;19(1):183. doi: 10.1186/s13063-018-2553-3.

17.

Identifying neuropathic pain in patients with multiple sclerosis: a cross-sectional multicenter study using highly specific criteria.

Solaro C, Cella M, Signori A, Martinelli V, Radaelli M, Centonze D, Sica F, Grasso MG, Clemenzi A, Bonavita S, Esposito S, Patti F, D'Amico E, Cruccu G, Truini A; Neuropathic Pain Special Interest Group of the Italian Neurological Society.

J Neurol. 2018 Apr;265(4):828-835. doi: 10.1007/s00415-018-8758-2. Epub 2018 Feb 5.

PMID:
29404736
18.

Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor.

Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, Cella M, Schmedt C, Colonna M.

Cell. 2018 Jan 25;172(3):534-548.e19. doi: 10.1016/j.cell.2017.11.037. Epub 2017 Dec 21.

19.

Two Distinct Myeloid Subsets at the Term Human Fetal-Maternal Interface.

Costa ML, Robinette ML, Bugatti M, Longtine MS, Colvin BN, Lantelme E, Vermi W, Colonna M, Nelson DM, Cella M.

Front Immunol. 2017 Oct 25;8:1357. doi: 10.3389/fimmu.2017.01357. eCollection 2017.

20.

Using wearable technology to detect the autonomic signature of illness severity in schizophrenia.

Cella M, Okruszek Ł, Lawrence M, Zarlenga V, He Z, Wykes T.

Schizophr Res. 2018 May;195:537-542. doi: 10.1016/j.schres.2017.09.028. Epub 2017 Oct 3.

21.

Effects of acute administration of donepezil or memantine on sleep-deprivation-induced spatial memory deficit in young and aged non-human primate grey mouse lemurs (Microcebus murinus).

Rahman A, Lamberty Y, Schenker E, Cella M, Languille S, Bordet R, Richardson J, Pifferi F, Aujard F.

PLoS One. 2017 Sep 18;12(9):e0184822. doi: 10.1371/journal.pone.0184822. eCollection 2017.

22.

The nuts and bolts of Cognitive Remediation: Exploring how different training components relate to cognitive and functional gains.

Cella M, Wykes T.

Schizophr Res. 2019 Jan;203:12-16. doi: 10.1016/j.schres.2017.09.012. Epub 2017 Sep 14.

PMID:
28919130
23.

A new generation computerised metacognitive cognitive remediation programme for schizophrenia (CIRCuiTS): a randomised controlled trial.

Reeder C, Huddy V, Cella M, Taylor R, Greenwood K, Landau S, Wykes T.

Psychol Med. 2017 Sep 4:1-11. doi: 10.1017/S0033291717001234. [Epub ahead of print]

24.

Effects of cognitive remediation on negative symptoms dimensions: exploring the role of working memory.

Cella M, Stahl D, Morris S, Keefe RSE, Bell MD, Wykes T.

Psychol Med. 2017 Sep 4:1-9. doi: 10.1017/S0033291717000757. [Epub ahead of print]

25.

Voltammetric Study of Some 3-Aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide Derivatives with Anti-Tumor Activities.

Miller EM, Xia Q, Cella ME, Nenninger AW, Mruzik MN, Brillos-Monia KA, Hu YZ, Sheng R, Ragain CM, Crawford PW.

Molecules. 2017 Aug 31;22(9). pii: E1442. doi: 10.3390/molecules22091442.

26.

TREM2 Maintains Microglial Metabolic Fitness in Alzheimer's Disease.

Ulland TK, Song WM, Huang SC, Ulrich JD, Sergushichev A, Beatty WL, Loboda AA, Zhou Y, Cairns NJ, Kambal A, Loginicheva E, Gilfillan S, Cella M, Virgin HW, Unanue ER, Wang Y, Artyomov MN, Holtzman DM, Colonna M.

Cell. 2017 Aug 10;170(4):649-663.e13. doi: 10.1016/j.cell.2017.07.023.

27.

Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+ T cells.

Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, Cortez VS, Caparon MG, Donia MS, Gilfillan S, Cella M, Gordon JI, Hsieh CS, Colonna M.

Science. 2017 Aug 25;357(6353):806-810. doi: 10.1126/science.aah5825. Epub 2017 Aug 3.

28.

Psychosocial intervention for negative symptoms: a note on meta-analyses.

Cella M, Preti A.

Br J Psychiatry. 2017 Aug;211(2):116. doi: 10.1192/bjp.211.2.116. No abstract available.

PMID:
28765308
29.

SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling.

Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML, Wang Q, White AJ, Gilfillan S, Cella M, Colonna M.

Nat Immunol. 2017 Sep;18(9):995-1003. doi: 10.1038/ni.3809. Epub 2017 Jul 31.

30.

Social cognition interventions for people with schizophrenia: a systematic review focussing on methodological quality and intervention modality.

Grant N, Lawrence M, Preti A, Wykes T, Cella M.

Clin Psychol Rev. 2017 Aug;56:55-64. doi: 10.1016/j.cpr.2017.06.001. Epub 2017 Jun 23. Review.

31.

Jak3 deficiency blocks innate lymphoid cell development.

Robinette ML, Cella M, Telliez JB, Ulland TK, Barrow AD, Capuder K, Gilfillan S, Lin LL, Notarangelo LD, Colonna M.

Mucosal Immunol. 2018 Jan;11(1):50-60. doi: 10.1038/mi.2017.38. Epub 2017 May 17.

32.

Feasibility and acceptability of brief cognitive remediation targeting metacognition in acute inpatients with psychosis: a case series.

Tsapekos D, Taylor R, Cella M.

Neuropsychol Rehabil. 2019 Apr;29(3):361-375. doi: 10.1080/09602011.2017.1301263. Epub 2017 Mar 20.

PMID:
28316273
33.

Computational EEG modelling of decision making under ambiguity reveals spatio-temporal dynamics of outcome evaluation.

Jollans L, Whelan R, Venables L, Turnbull OH, Cella M, Dymond S.

Behav Brain Res. 2017 Mar 15;321:28-35. doi: 10.1016/j.bbr.2016.12.033. Epub 2016 Dec 26.

PMID:
28034803
34.

Cognitive remediation for negative symptoms of schizophrenia: A network meta-analysis.

Cella M, Preti A, Edwards C, Dow T, Wykes T.

Clin Psychol Rev. 2017 Mar;52:43-51. doi: 10.1016/j.cpr.2016.11.009. Epub 2016 Nov 28. Review.

35.

Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state.

Swiecki M, Miller HL, Sesti-Costa R, Cella M, Gilfillan S, Colonna M.

Mucosal Immunol. 2017 Jul;10(4):936-945. doi: 10.1038/mi.2016.99. Epub 2016 Nov 9.

36.

The beat of social cognition: Exploring the role of heart rate variability as marker of mentalizing abilities.

Okruszek Ł, Dolan K, Lawrence M, Cella M.

Soc Neurosci. 2017 Oct;12(5):489-493. doi: 10.1080/17470919.2016.1244113. Epub 2016 Oct 15.

PMID:
27696950
37.

The Automatic Detection of Chronic Pain-Related Expression: Requirements, Challenges and the Multimodal EmoPain Dataset.

Aung MSH, Kaltwang S, Romera-Paredes B, Martinez B, Singh A, Cella M, Valstar M, Meng H, Kemp A, Shafizadeh M, Elkins AC, Kanakam N, de Rothschild A, Tyler N, Watson PJ, de C Williams AC, Pantic M, Bianchi-Berthouze N.

IEEE Trans Affect Comput. 2016 Oct-Dec;7(4):435-451. doi: 10.1109/TAFFC.2015.2462830. Epub 2015 Jul 30.

38.

Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Paolucci S, Martinuzzi A, Scivoletto G, Smania N, Solaro C, Aprile I, Armando M, Bergamaschi R, Berra E, Berto G, Carraro E, Cella M, Gandolfi M, Masciullo M, Molinari M, Pagliano E, Pecchioli C, Roncari L, Torre M, Trabucco E, Vallies G, Zerbinati P, Tamburin S; Italian Consensus Conference on Pain in Neurorehabilitation (ICCPN).

Eur J Phys Rehabil Med. 2016 Dec;52(6):827-840. Epub 2016 Aug 31.

39.

The Transcription Factor AP4 Mediates Resolution of Chronic Viral Infection through Amplification of Germinal Center B Cell Responses.

Chou C, Verbaro DJ, Tonc E, Holmgren M, Cella M, Colonna M, Bhattacharya D, Egawa T.

Immunity. 2016 Sep 20;45(3):570-582. doi: 10.1016/j.immuni.2016.07.023. Epub 2016 Aug 23.

40.

Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches.

Smania G, Baiardi P, Ceci A, Cella M, Magni P.

CPT Pharmacometrics Syst Pharmacol. 2016 Aug;5(8):402-10. doi: 10.1002/psp4.12092. Epub 2016 Aug 17.

41.

Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.

Song W, Hooli B, Mullin K, Jin SC, Cella M, Ulland TK, Wang Y, Tanzi RE, Colonna M.

Alzheimers Dement. 2017 Apr;13(4):381-387. doi: 10.1016/j.jalz.2016.07.004. Epub 2016 Aug 9.

42.

The optimisation of experience sampling protocols in people with schizophrenia.

Edwards CJ, Cella M, Tarrier N, Wykes T.

Psychiatry Res. 2016 Oct 30;244:289-93. doi: 10.1016/j.psychres.2016.07.048. Epub 2016 Jul 26.

PMID:
27512917
43.

A question of time: A study of time use in people with schizophrenia.

Cella M, Edwards C, Wykes T.

Schizophr Res. 2016 Oct;176(2-3):480-484. doi: 10.1016/j.schres.2016.06.033. Epub 2016 Jul 12.

44.

Type 1 Interferons Induce Changes in Core Metabolism that Are Critical for Immune Function.

Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, Patterson A, Smith AM, Chang CH, Liu Z, Artyomov MN, Pearce EL, Cella M, Pearce EJ.

Immunity. 2016 Jun 21;44(6):1325-36. doi: 10.1016/j.immuni.2016.06.006.

45.

Model-Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches.

Smania G, Baiardi P, Ceci A, Magni P, Cella M.

CPT Pharmacometrics Syst Pharmacol. 2016 Jun;5(6):305-12. doi: 10.1002/psp4.12083. Epub 2016 Jun 1.

46.

Distinct Gene Regulatory Pathways for Human Innate versus Adaptive Lymphoid Cells.

Koues OI, Collins PL, Cella M, Robinette ML, Porter SI, Pyfrom SC, Payton JE, Colonna M, Oltz EM.

Cell. 2016 May 19;165(5):1134-1146. doi: 10.1016/j.cell.2016.04.014. Epub 2016 May 5.

47.

Transforming Growth Factor-β Signaling Guides the Differentiation of Innate Lymphoid Cells in Salivary Glands.

Cortez VS, Cervantes-Barragan L, Robinette ML, Bando JK, Wang Y, Geiger TL, Gilfillan S, Fuchs A, Vivier E, Sun JC, Cella M, Colonna M.

Immunity. 2016 May 17;44(5):1127-39. doi: 10.1016/j.immuni.2016.03.007. Epub 2016 May 3.

48.

TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques.

Wang Y, Ulland TK, Ulrich JD, Song W, Tzaferis JA, Hole JT, Yuan P, Mahan TE, Shi Y, Gilfillan S, Cella M, Grutzendler J, DeMattos RB, Cirrito JR, Holtzman DM, Colonna M.

J Exp Med. 2016 May 2;213(5):667-75. doi: 10.1084/jem.20151948. Epub 2016 Apr 18.

49.

The Inhibitory Receptor NKG2A Sustains Virus-Specific CD8⁺ T Cells in Response to a Lethal Poxvirus Infection.

Rapaport AS, Schriewer J, Gilfillan S, Hembrador E, Crump R, Plougastel BF, Wang Y, Le Friec G, Gao J, Cella M, Pircher H, Yokoyama WM, Buller RM, Colonna M.

Immunity. 2015 Dec 15;43(6):1112-24. doi: 10.1016/j.immuni.2015.11.005. Epub 2015 Dec 8.

50.

Exploring the association between the Iowa Gambling Task and community functioning in people with schizophrenia.

Stratta P, Cella M, Di Emidio G, Collazzoni A, Rossi A.

Psychiatr Danub. 2015 Dec;27(4):371-7.

Supplemental Content

Support Center